🇺🇸 FDA

Intelligence · Patent portfolio

Compass Therapeutics Patents

Full USPTO pharma patent portfolio for Compass Therapeutics — grant dates, expiration, and drug cross-links.

Patents
100
Expiring ≤24m
0

Quick answer

Compass Therapeutics has 100 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 3

  1. US 12377112

    Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12312375

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12286483

    Method of treating cancer using CD137 antibodies and PD-1 antagonists

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12186285

    Compositions and methods of treatment for tinea pedis

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12070594

    Biomedical electrode with anti-microbial properties

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11970538

    Multispecific binding constructs against checkpoint molecules and uses thereof

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11939346

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11865179

    Progesterone formulations having a desirable PK profile

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11865126

    Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11851451

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11851497

    CD137 antibodies and tumor antigen-targeting antibodies and uses thereof

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11793819

    Natural combination hormone replacement formulations and therapies

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11766558

    Biomedical electrode with anti-microbial properties

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11752207

    Agonist antibodies that bind human CD137 and uses thereof

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11738035

    Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11718679

    CD137 antibodies and PD-1 antagonists and uses thereof

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11661617

    Processes for the production of tryptamines

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11633405

    Steroid hormone pharmaceutical formulations

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11629159

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11622933

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11564935

    Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11529360

    Natural combination hormone replacement formulations and therapies

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11505564

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11497709

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11447510

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11351182

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11304959

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11266661

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11246875

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11241445

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11180517

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11166963

    Natural combination hormone replacement formulations and therapies

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11149044

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11123283

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11116717

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11110099

    Natural combination hormone replacement formulations and therapies

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11103513

    Natural combination hormone replacement formulations and therapies

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11065197

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11046769

    Multispecific binding constructs against checkpoint molecules and uses thereof

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11033626

    Progesterone formulations having a desirable pk profile

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10973869

    Methods of treating cardiomyopathy associated with genetic disorders

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10960045

    Methods and compositions for the treatment of epidermolysis bullosa

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10954259

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10947257

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10912783

    Formulations for solubilizing hormones

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10888516

    Soluble estradiol capsule for vaginal insertion

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10835487

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10821092

    Viscous topical ocular formulations

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Compass Therapeutics have?

100 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Compass Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.